Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Miniaturized hairs stay connected to muscle in alopecia areata, allowing possible regrowth, but not in androgenetic alopecia.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

Hair and serum levels of zinc, copper, and iron are similar in people with alopecia areata and healthy individuals.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blocking IL-12/IL-23 does not help with hair loss in alopecia areata for mice or humans.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

TGPC plus CGT is effective and safe for treating severe alopecia areata in children.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Hydroxychloroquine may help treat alopecia areata in children.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Illness perception affects mental health and quality of life in Chinese alopecia patients.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.